Skip to main content

Table 2 Characteristics of nocturnal acid breakthrough (NAB) monitored using intragastric pH monitoring following a single dose (20 mg) of rabeprazole, omeprazole and placebo in 18 obese volunteers. Values are medians and interquartiles (Q1-Q3)

From: Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole

NAB

Rabeprazole

Omeprazole

Placebo

p (OvsR)

Number

1 (1–2)

2 (1–3)

2 (1–3)

0.04

Minimal pH

0.7 (0.6-0.9)

0.5 (0.3-0.8)

0.4 (0.3-0.6)

0.53

Median pH

1.4 (1.2-1.5)

1.3 (0.8-1.5)

0.9 (0.7-1.1)

0.47

Duration (h)

5.1 (3.4-6.2)

6.5 (4.6-8.9)

9.2 (7.9-9.9)

0.11